Cargando...

Trastuzumab emtansine in the treatment of HER2-positive metastatic breast cancer in Japanese patients

Anti-HER2 agents, such as trastuzumab, lapatinib, trastuzumab emtansine (T-DM1), and pertuzumab, are standard agents in the treatment of breast cancer overexpressing the human epidermal growth factor receptor 2 (HER2). Trastuzumab is the first approved HER2-targeted agent. Subsequent developments in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Sawaki, Masataka
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3998859/
https://ncbi.nlm.nih.gov/pubmed/24833915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BCTT.S44047
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!